


Healthcare Industry News: HIV/AIDS
News Release - January 29, 2018
Theravance Biopharma and Mylan Announce FDA Acceptance of New Drug Application for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease
Source: Theravance Biopharma
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
